. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: J Am Med Dir Assoc. 2017 Feb 1;18(2):99–104. doi: 10.1016/j.jamda.2016.11.010

TABLE 1.

Pneumococcal Vaccines Available in the United States

Vaccine	Vaccine Type and Content	Brand Name (Manufacturer)	Comments
PPSV 23	Pneumococcal polysaccharide – contains cell capsule antigens from 23 pneumococcus subtypes	Pneumovax 23 (Merck)	First pneumococcal vaccine. Licensed in 1983.
PCV 13	Pneumococcal conjugate – contains cell capsule antigens from 13 pneumococcus subtypes combined with diphtheria antigen	Prevnar 13 (Wyeth / Pfizer)	Approved by FDA in 2010. Conjugate formulation was developed to enhance immunogenicity.
PCV 7	Pneumococcal conjugate – contains cell capsule antigens from 7 common pneumococcus subtypes combined with diphtheria antigen	Prevnar 7 (Wyeth / Pfizer)	Licensed for children only. Not used in older adults.